🇺🇸 FDA
Patent

US 7388002

Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

granted A61KA61K36/28A61K38/208

Quick answer

US patent 7388002 (Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases) held by BioCryst Pharmaceuticals, Inc. expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K36/28, A61K38/208, A61K38/212, A61P